- Dijkman GA, Debruyne FMJ. Epidemiology of prostate cancer. Eur Urol 1996; 30: 281–95.
Google Scholar
- Jacobs SC. Spread of prostatic cancer to bone. Urology 1983; XXI: 337–44.
Google Scholar
- Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 1997; 32: 175–253.
Google Scholar
- Liotta LA, Mandler R, Murano G et al. Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 1986; 83: 3302–6.
Google Scholar
- Carsberg CJ, Myers KA, Stern PL. Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells. Int J Cancer 1996; 68: 84–92.
Google Scholar
- Southall PJ, Boxer GM, Bagshawe KD et al. Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 1990; 61: 89–95.
Google Scholar
- Cronauer MV, Hittmair A, Eder IE et al. Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate 1997; 31: 223–33.
Google Scholar
- Jin L, Fuchs A, Schnitt SJ et al. Expression of scatter factor and c_met_ receptor in benign and malignant breast tissue. Cancer 1997; 79: 749–60.
Google Scholar
- Rosen EM, Nigam SK, Goldberg ID. Scatter factor and the c-Met receptor: a paradigm for mesenchymal-epithelial interaction. J Cell Biol 1994; 127: 1783–7.
Google Scholar
- Naldini L, Tamagnone L, Vigna E et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992; 11: 4825–33.
Google Scholar
- Pisters LL, Troncoso P, Zhau HE et al. c-Met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 1995; 154: 293–8.
Google Scholar
- Hiscox S, Jiang WG. Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/ scatter factor. Biochem Biophys Res Comm 1997; 233: 1–5.
Google Scholar
- Nishino T, Hisha H, Nishino N et al. Hepatocyte growth factor as a hematopoietic regulator. Blood 1995; 85: 3093–100.
Google Scholar
- Humphrey PA, Zhu X, Zarnegar R et al. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 1995; 147: 386–96.
Google Scholar
- Lang SH, Clarke NW, George NJR et al. Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma. Prostate 1998; 34: 203–13.
Google Scholar
- Coutinho LH, Gilleece MH, de Wynter EA et al. Clonal and longterm cultures using human bone marrow. In Testa NG, Molineux G (eds): Haemopoiesis: A Practical Approach. Oxford: IRL Press 1993; 75–106.
Google Scholar
- Bhargava M, Joseph A, Knesel J et al. Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. Cell Growth Differentiation 1992; 3: 11–20.
Google Scholar
- Vilá MR, Nakamura T, Real FX. Hepatocyte growth factor is a potent mitogen for normal human pancreas cell in vitro. Lab. Invest 1995; 73: 409–18.
Google Scholar
- Sherwood ER, Fong C-J, Lee C, Kozlowski JM. Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology 1992; 130: 2955–63.
Google Scholar
- Matsumoto K. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 1994; 269: 31807–13.
Google Scholar
- Corps AN, Sowter HM, Smith SK. Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met. Int J Cancer 1997; 73: 151–5.
Google Scholar
- Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol 1993; 121: 145–54.
Google Scholar
- Hartmann G, Naldini L, Weidner KM et al. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci USA 1992; 89: 11574–8.
Google Scholar
- Trusolino L, Pugliese L, Comoglio PM. Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB 1998; 12: 1267–80.
Google Scholar
- Seslar S, Nakamura T, Byers S. Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: a role for transforming growth factor-b activation. Endocrinology 1995; 136: 1945–53.
Google Scholar
- Degeorges A, Tatoud R, Fauvel-Lafeve F et al. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer 1996; 68: 207–14.
Google Scholar
- Bourhis XFDL, Berthois Y, Millot G et al. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer 1997; 71: 42–8.
Google Scholar
- Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconjugate J 1997; 14: 577–84.
Google Scholar
- Lang SH, Clarke NW, George NJR, Testa NG. Primary prostatic epithelial cell binding to human bone marrow stroma and the role of α2α1 integrin. Clin Exp Metastasis 1997; 15: 218–27.
Google Scholar
- Kostenuik PJ, Sanchez-Sweatman O, Orr FW, Singh G. Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the α2α1 integrin. Clin Exp Metastasis 1996; 14: 19–26.
Google Scholar
- Pienta KJ, Isaacs WB, Vindivich D, Coffey DS. The effects of basic fibroblast growth factor and suramin on cell motility and growth of rat prostate cancer cells. J Urol 1991; 145: 199–202.
Google Scholar